FluidAI wins FDA clearance for Origin post-op monitoring device

FluidAI Medical recently announced it received FDA 510(k) clearance for its Origin real-time monitoring system for patients recovering from surgery.

Origin is an inline sensing device that the company designed to connect to standard surgical drains and continuously provide bedside pH data. The company said the system can operate on its own or integrate with Stream Care, FluidAI’s AI-assisted surgical platform.

“This is a foundational step toward a future of data-driven, post-operative recovery. Origin will enable clinicians to observe subtle biochemical shifts that may herald optimal recovery or foreshadow complications in the near future,” CEO Youssef Helwa said. “Its continuous sensing unlocks a new data layer, one that will enable our predictive models, and will pave the way for a new era of intelligent recovery, where patient care becomes proactive rather than reactive.”

See full article (https://www.massdevice.com/fluidai-wins-fda-clearance-for-origin-post-op-monitoring-device/)